相关实验视频

Updated: Jun 20, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

乳腺癌诊断过程中的PALB2分析:一个意大利单心经验

Maria Grazia Tibiletti¹, Ileana Carnevali^1,2, Sofia Facchi^1,2

¹Research Center for Familial and Hereditary Tumors, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy.

|October 25, 2024

概括

对BRCA1,BRCA2和PALB2基因的生殖基因测试对于遗传性乳腺和卵巢癌综合征至关重要. 尽管PALB2的病原性变异比BRCA少,但与早期发病,晚期乳腺癌有关,因此应纳入临床实践.

科学领域:

遗传学遗传学是一个
在瘤学瘤学.
临床诊断临床诊断临床诊断

背景情况:

生殖系BRCA1和BRCA2测试是遗传性乳腺和卵巢癌综合征的标准.
生殖系PALB2致病变体也会增加癌症风险,但在意大利,与BRCA1/BRCA2一起进行系统分析并不常见.

研究的目的:

报告ASST Sette Laghi的遗传咨询服务在分析402名怀疑遗传性乳腺和卵巢癌综合征的患者中的经验.
评估这个队列中生殖线BRCA1,BRCA2和PALB2变异的频率和临床意义.

主要方法:

对BRCA1,BRCA2和PALB2基因进行生殖系遗传测试.
对402名疑似遗传性乳腺和卵巢癌综合征患者的分析.
变种载体的血统分析.

主要成果:

在1.2%的患者中发现了PALB2致病变体,而BRCA1则为3.5%,BRCA2则为3.2%.
PALB2变异与乳腺癌发病年龄显著较小 (平均年龄为40.25岁) 和临床晚期相关.
所有PALB2致病变体携带者都有与乳腺和卵巢癌综合征一致的家族病史.

结论:

对BRCA1,BRCA2和PALB2的生殖线分析应纳入乳腺癌的临床实践.
识别PALB2载体可以转向特定的监测协议,改善患者管理.

关键词:

在 HBOC HBOC HBOC 在PALB2中,PALB2是PALB2.乳腺癌乳腺癌乳腺癌生殖线分析的生殖线分析.

更多相关视频

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...